---
layout: post
title: "Revocation of Authorization of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability"
date: 2026-02-04 21:49:04 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-15556
original_published: 2025-08-15 00:00:00 +0000
significance: 8.00
---

# Revocation of Authorization of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** August 15, 2025 00:00 UTC
**Document Number:** 2025-15556

## Summary

The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to LumiraDx UK Ltd. for the LumiraDx SARS CoV-2 RNA STAR Complete. FDA revoked the Authorization under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as requested by the Authorization holder. The revocation, which includes an explanation of the reason for revocation, is reprinted at the end of this document.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/08/15/2025-15556/revocation-of-authorization-of-emergency-use-of-in-vitro-diagnostic-device-for-detection-andor)
- API: https://www.federalregister.gov/api/v1/documents/2025-15556

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
